To confirm this, we further validated a number of MYC and E2F targeted genes in three different human SCLC cell lines (NCI-H1963, NCI-H1882, and NCI-H748) treated with either DMSO or iBAP-II using real-time PCR. The gene discussed is MYC; the disease is small cell lung carcinoma.